Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Clovis Oncology, Inc. | 138,494 | reported | 02 Nov 2015 | tx 56+247,433−111,722 |
| Sienna Biopharmaceuticals, Inc. | 10,000 | reported | 01 Jun 2018 | tx 2+16,700 |
| ZOGENIX, INC. | 0 | reported | 07 Mar 2022 | tx 41+436,939−115,713 |
| PHARMION CORP | 0 | reported | 07 Mar 2008 | tx 27+294,500−329,034 |
| Somaxon Pharmaceuticals, Inc. | 0 | reported | 06 Mar 2013 | tx 29+415,180−124,162 |
| Receptos, Inc. | 0 | reported | 27 Aug 2015 | tx 9+35,900−35,900 |
4 purchases reported after at least 12 months of silence — most recent on 01 Aug 2017.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Mar 2022 | TENDER | ZOGENIX, INC. | 3,027 | — | |
| 07 Mar 2022 | OTHER | ZOGENIX, INC. | 9,000 | — | deriv |
| 07 Mar 2022 | OTHER | ZOGENIX, INC. | 20,000 | — | deriv |
| 07 Mar 2022 | OTHER | ZOGENIX, INC. | 22,000 | — | deriv |
| 07 Mar 2022 | OTHER | ZOGENIX, INC. | 6,250 | — | deriv |
| 07 Mar 2022 | OTHER | ZOGENIX, INC. | 20,000 | — | deriv |
| 01 Feb 2022 | EXERCISE | ZOGENIX, INC. | 1,250 | 12.00 USD | |
| 01 Feb 2022 | SALE | ZOGENIX, INC. | 1,250 | 26.04 USD | |
| 01 Feb 2022 | EXERCISE | ZOGENIX, INC. | 1,250 | 0.00 USD | deriv |
| 19 Jan 2022 | SALE | ZOGENIX, INC. | 15,000 | 26.09 USD | |
| 19 Jan 2022 | EXERCISE | ZOGENIX, INC. | 4,375 | 14.88 USD | |
| 19 Jan 2022 | EXERCISE | ZOGENIX, INC. | 6,250 | 15.04 USD | |
| 19 Jan 2022 | EXERCISE | ZOGENIX, INC. | 4,375 | 12.00 USD | |
| 19 Jan 2022 | EXERCISE | ZOGENIX, INC. | 6,250 | 0.00 USD | deriv |
| 19 Jan 2022 | EXERCISE | ZOGENIX, INC. | 4,375 | 0.00 USD | deriv |
| 19 Jan 2022 | EXERCISE | ZOGENIX, INC. | 4,375 | 0.00 USD | deriv |
| 27 May 2021 | GRANT_AWARD | ZOGENIX, INC. | 22,000 | 0.00 USD | deriv |
| 29 May 2020 | GRANT_AWARD | ZOGENIX, INC. | 13,000 | 0.00 USD | deriv |
| 22 May 2019 | GRANT_AWARD | ZOGENIX, INC. | 13,000 | 0.00 USD | deriv |
| 26 Nov 2018 | SALE | ZOGENIX, INC. | 1,468 | 42.08 USD | |
| 02 Oct 2018 | EXERCISE | ZOGENIX, INC. | 218 | 20.00 USD | |
| 02 Oct 2018 | EXERCISE | ZOGENIX, INC. | 1,250 | 28.00 USD | |
| 02 Oct 2018 | EXERCISE | ZOGENIX, INC. | 218 | 0.00 USD | deriv |
| 02 Oct 2018 | EXERCISE | ZOGENIX, INC. | 1,250 | 0.00 USD | deriv |
| 01 Jun 2018 | GRANT_AWARD | Sienna Biopharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |